[Pharmacogenetic-based risk assessment of antipsychotic-induced extrapyramidal symptoms].
Kirnichnaya, K A
[Pharmacogenetic-based risk assessment of antipsychotic-induced extrapyramidal symptoms]. [electronic resource] - Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2015 - 113-125 p. digital
Publication Type: English Abstract; Journal Article; Review
1997-7298
10.17116/jnevro201511541113-125 doi
Antipsychotic Agents--adverse effects
Basal Ganglia Diseases--chemically induced
Genetic Markers--genetics
Genetic Predisposition to Disease
Genetic Testing
Humans
Pharmacogenetics--trends
Risk Assessment
[Pharmacogenetic-based risk assessment of antipsychotic-induced extrapyramidal symptoms]. [electronic resource] - Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2015 - 113-125 p. digital
Publication Type: English Abstract; Journal Article; Review
1997-7298
10.17116/jnevro201511541113-125 doi
Antipsychotic Agents--adverse effects
Basal Ganglia Diseases--chemically induced
Genetic Markers--genetics
Genetic Predisposition to Disease
Genetic Testing
Humans
Pharmacogenetics--trends
Risk Assessment